Asston Pharmaceuticals Ltd
₹0.00▲ +0.00 (+0.00%)
ASSTONPHARMACEUTICALSLTD·NSE·Capital Goods
Market Cap
116.90 Cr
PE Ratio
30.20
Volume
—
Day High - Low
—
52W High-Low
126.10 - 60.00
₹0.00▲ +0.00 (+0.00%)
Market Cap116.90 Cr
PE Ratio30.20
Volume—
Day High - Low—
52W High-Low126.10 - 60.00
Asston Pharmaceuticals Ltd (ASSTONPHARMACEUTICALSLTD): company summary
Asston Pharmaceuticals Ltd (ASSTONPHARMACEUTICALSLTD) is a micro-cap Capital Goods company valued at ₹117 crore operating in Other Electrical Equipment on the NSE and BSE.
Asston Pharmaceuticals Ltd (ASSTONPHARMACEUTICALSLTD) is a micro-cap Capital Goods company valued at ₹117 crore operating in Other Electrical Equipment on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 57.3% a year over three years; profit grew 55.3% a year, behind revenue — margins are under pressure. Return on equity is 15.5%.
- Valuation multiples
- The stock trades at 30.2 times earnings, 1.76 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
6.1/10
Fair
Fair Value
Sign in to see
ROE
15.50%
Strong
P/E
30.20x
Fair
Debt / Equity
0.13
Low
Industry
Capital Goods
Other Electrical Equipment
Overall View
Fair
Price performance
52W₹60.00
₹126.10
DocStoX take
Supported by growth (8.1) and quality (6.5), but weakest on risk (4.8). Scored on 4 of 5 measures.
DocStoX score
Medium confidence6.1
/10
Fair
Quality
Solid
ROE 15.5%
Valuation
Fair
P/E 30.2×
Growth
Strong
Revenue +57.3% 3Y CAGR
Risk
Elevated
D/E 0.13
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹117 Cr
52W High / Low
₹126 / ₹60
Dividend Yield
0.00%
Promoter Holding
50.66%
EPS (TTM)
₹6.14
Book Value
₹60.96
Key highlights
- Revenue compounding 57% a year
- Profit compounding 55% a year
- Capital works hard — ROCE 37%
- Small ₹117 cr company — thinner liquidity
4 Positives1 Watchout
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Capital Goods stocks · Other Electrical Equipment
Explore Asston Pharmaceuticals Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Asston Pharmaceuticals Ltd peers in Capital Goods
Other Capital Goods stocks on the NSE & BSE. See the full Capital Goods sector list.
Related tools & concepts
Value Asston Pharmaceuticals Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing